Stay updated on Brentuximab Vedotin Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.

Latest updates to the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 to the site; removed the government funding lapse notice and the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a government funding lapse notice at the top of the page. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check28 days agoChange DetectedMinor UI and metadata updates include a glossary display, new QC-related metadata labels, and a revision bump to v3.4.0; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page. No substantive study content was changed.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a consolidated Locations section listing state-level sites (Arizona, Arkansas, California, Colorado, Illinois, Kansas, Kentucky, Minnesota, Nebraska, New York, Ohio, Oregon, Texas, Virginia, Washington) and updated metadata to Last Update Posted (Estimated) and Revision: v3.3.3. The old per-state location headers and prior revision indicator were removed.SummaryDifference1%

- Check71 days agoChange DetectedNew study sites were added in Texas and Virginia, including Texas Oncology - Central South (Balcones Dr) and James Casey, South Hill VA, VCU Health Community Memorial Hospital, and Oncology & Hematology Associates of Southwest Virginia, Inc. Some sites in Virginia Beach, Newport News, and Williamsburg were removed, and the reported total number of locations updated from 92 to 88.SummaryDifference0.7%

Stay in the know with updates to Brentuximab Vedotin Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.